|
Volumn 4, Issue 4, 2008, Pages 168-169
|
Why do some biologic agents induce psoriasis or psoriasiform lesions?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGIC FACTORS AND AGENTS ACTING ON THE IMMUNE SYSTEM;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
RHEUMATOID FACTOR;
RITUXIMAB;
SUPERANTIGEN;
TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
USTEKINUMAB;
ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
ANKYLOSING SPONDYLITIS;
BACTERIAL INFECTION;
CHLAMYDIA TRACHOMATIS;
DIAGNOSTIC ERROR;
DRUG ERUPTION;
DRUG WITHDRAWAL;
ENTERITIS;
HUMAN;
INTERFERON PRODUCTION;
LYMPHOCYTIC INFILTRATION;
NONHUMAN;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
PSORIASIS;
PSORIASIS VULGARIS;
PSORIATIC ARTHRITIS;
PUSTULOSIS PALMOPLANTARIS;
REVIEW;
RHEUMATOID ARTHRITIS;
SKIN INFECTION;
VASCULITIS;
YERSINIA;
ANIMAL;
ARTICLE;
BIOLOGICAL THERAPY;
DRUG ANTAGONISM;
IMMUNOLOGY;
ANIMALS;
ANTIBODIES;
BIOLOGICAL THERAPY;
HUMANS;
PSORIASIS;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 45549094151
PISSN: 17458382
EISSN: 17458390
Source Type: Journal
DOI: 10.1038/ncprheum0738 Document Type: Review |
Times cited : (8)
|
References (10)
|